Skip to main content
Article thumbnail
Location of Repository

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

By Erik Serrao, Srinivas Odde, Kavya Ramkumar and Nouri Neamati

Abstract

Correction to Erik Serrao, Srinivas Odde, Kavya Ramkumar and Nouri Neamati: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology 2009, 6:25. Since the recent publication of our article (Neamati, Retrovirology 2009, 6:25), we have noticed an error which we would like to correct and we would like to apologise to the readers for this mistake

Topics: Correction
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2672074
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2007). Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
    2. (2008). Krystal MR: Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
    3. (2009). Odde Srinivas, Ramkumar Kavya, Neamati Nouri: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.